Catheter reprices stock options for CEO and CFO
Catheter Precision repriced outstanding stock options for CEO David A. Jenkins and CFO Philip Anderson to $0.152 per share (pre-reverse split), effective with its 1-for-10 reverse split.
Catheter Precision repriced outstanding stock options for CEO David A. Jenkins and CFO Philip Anderson to $0.152 per share (pre-reverse split), effective with its 1-for-10 reverse split.